Packages for men

The package provides information about the condition of the male body’s hematopoietic system; sex hormone levels; carbohydrate, protein, and fat metabolisms as well as liver, pancreas, muscle and kidney functions.  In this package the function and regulation of thyroid hormones as well as levels of essential ions and vitamin D, and markers of possible inflammation are examined. The package also includes general urine and sediment tests.

• Carbohydrate metabolism: glucose (GLU, fasting), insulin (fasting)
• Liver function: direct bilirubin, total bilirubin, gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST,GOT), alanine aminotransferase (ALT,GPT)
• Fat metabolism: cholesterol, LDL cholesterol (LDL), HDL cholesterol (HDL), triglyceride (TG)
• Kidney function: direct bilirubin, total bilirubin, carbamide (Urea, N, BUN), creatinine/ EGFR, uric acid
• Minerals and trace elements: iron (Fe), potassium (K), sodium (Na), phosphorus (P), chloride (Cl), calcium (Ca), magnesium (Mg)
• Protein metabolism: albumin (ALB), total protein (TP)
• Inflammatory parameters: alkaline phosphatase (ALP), C-reactive protein (ultra-sensitive CRP)
• Thyroid function: free triiodothyronine (FT3), free thyroxine (FT4)
• Regulation of thyroid hormones: thyroid stimulating hormone (TSH)
• Pancreas function: alpha amylase (AMY), insulin (fasting)
• Sex hormones: follicle-stimulating hormone (FSH), luteinizing hormone (LH), sexual hormone binding globulin (SHBG), testosterone, dehydroepiandrosterone sulfate (DHEAS)
• Muscle metabolism: creatine kinase (CK)
• Function of the hematopoietic system: iron (Fe), ferritin, transferrin (Trf)
• Blood clotting (Coagulation): activated partial thromboplastin time (APTI), prothrombin+INR (PT+INR)
• Vitamins: vitamin D3 (D3)
• Blood count with 22 parameters: Blood count: white blood cell (WBC), red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean cell volume (MCV), mean cell (MCH), mean cell hemoglobin concentration (MCHC). Differential count parameters (expressed in % and absolute value): neutrophils (NEUT), lymphocytes (LYMPH), monocytes (MONO), eosinophils (EOS), basophils (BASO), large unstained cells (LUC). Thrombocyte parameters: thrombocyte/platelet (PLT), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT).
• Reticulocyte parameters: reticulocyte (% RETIC), reticulocyte (abs RETIC)
• Urine sediment analysis: red blood cells, white blood cells, white blood cell conglomerates, bacteria, fungi, squamous epithelial cells, non-squamous epithelial cells, crystals, hyaline cylinder, pathologic cylinder, sperm, mucus
• General urine analysis: glucose, protein, blood, bilirubin, urobilinogen, pH, ketones, nitrites, white blood cells, specific gravity, color, clarity/turbidity (protein/creatinine ratio (calculated).

Information about the package:

The package provides information about the condition of the male body’s hematopoietic system; sex hormone levels; carbohydrate, protein, and fat metabolisms as well as liver, pancreas, muscle and kidney functions.  In this package the function and regulation of thyroid hormones as well as levels of essential ions and vitamin D, and markers of possible inflammation are examined. The package also includes a tumor marker test (PSA) as well as general urine and sediment tests.

• Carbohydrate metabolism: glucose (GLU, fasting), insulin (fasting)
• Liver function: direct bilirubin, total bilirubin, gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT)
• Fat metabolism: cholesterol, LDL cholesterol (LDL), HDL cholesterol (HDL), triglyceride (TG)
• Kidney function: direct bilirubin, total bilirubin, carbamide (Urea, N, BUN), creatinine/ EGFR, uric acid
• Minerals and trace elements: iron (Fe), potassium (K), sodium (Na), phosphorus (P), chloride (Cl), calcium (Ca), magnesium (Mg)
• Protein metabolism: albumin (ALB), total protein (TP)
• Inflammatory parameters: alkaline phosphatase (ALP), C-reactive protein (ultra-sensitive CRP)
• Thyroid function: free triiodothyronine (FT3), free thyroxine (FT4), anti-thyroid peroxidase antibody (anti-TPO), thyroglobulin (Tg)
• Regulation of thyroid hormones: thyroid stimulating hormone (TSH)
• Pancreas function: alpha amylase (AMY), insulin (fasting)
• Sex hormones: follicle-stimulating hormone (FSH), luteinizing hormone (LH), sexual hormone binding globulin (SHBG), testosterone, androstenedione, dehydroepiandrosterone sulfate (DHEAS)
• Muscle metabolism: creatine kinase (CK)
• Function of the hematopoietic system: iron (Fe), ferritin, transferrin (Trf)
• Tumor markers: prostate-specific antigen (PSA)
• Blood clotting (Coagulation): activated partial thromboplastin time (APTI), prothrombin+INR (PT+INR)
• Vitamins: vitamin B12 (B12), vitamin D3 (D3)
• Blood count with 22 parameters: Blood count: white blood cell (WBC), red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean cell volume (MCV), mean cell (MCH), mean cell hemoglobin concentration (MCHC). Differential count parameters (expressed in % and absolute value): neutrophils (NEUT), lymphocytes (LYMPH), monocytes (MONO), eosinophils (EOS), basophils (BASO), large unstained cells (LUC). Thrombocyte parameters: thrombocyte/platelet (PLT), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT).
• Reticulocyte parameters: reticulocyte (% RETIC), reticulocyte (abs RETIC)
• Urine sediment analysis: red blood cells, white blood cells, white blood cell conglomerates, bacteria, fungi, squamous epithelial cells, non-squamous epithelial cells, crystals, hyaline cylinder, pathologic cylinder, sperm, mucus
• General urine analysis: glucose, protein, blood, bilirubin, urobilinogen, pH, ketones, nitrites, white blood cells, specific gravity, color, clarity/turbidity (protein/creatinine ratio (calculated).

Information about the package:

Hair loss has many causes. In addition to genetic causes, there are often hormonal changes (testosterone/estrogen ratio, thyroid disorders), inflammation, vitamin deficiencies, infections, skin diseases, chemical effects, poisoning, radiation and burns, prolonged stress, temporary weakening of the immune system, organ diseases, drug effects. Hair loss may also be triggered by a decrease in the levels of certain ions (iron, zinc, calcium).

• Carbohydrate metabolism: glucose (GLU, fasting), insulin
• Liver function: direct bilirubin, total bilirubin, gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT)
• Fat metabolism: cholesterol, LDL cholesterol (LDL), HDL cholesterol (HDL), triglyceride (TG)
• Kidney function: direct bilirubin, total bilirubin, carbamide (Urea, N, BUN), creatinine/ EGFR, uric acid
• Minerals and trace elements: iron (Fe), magnesium (Mg), zinc (Zn)
• Protein metabolism: albumin (ALB), total protein (TP)
• Inflammatory parameters: alkaline phosphatase (ALP), C-reactive protein (ultra-sensitive CRP)
• Vitamins: vitamin B12 (B12), vitamin D3 (D3), folic acid
• Pancreas function: insulin
• Sex hormones: follicle-stimulating hormone (FSH), luteinizing hormone (LH), sexual hormone binding globulin(SHBG), testosterone, dehydroepiandrosterone sulfate (DHEAS)
• Thyroid function: anti-thyroid peroxidase antibody (anti-TPO)
• Regulation of thyroid hormones: thyroid stimulating hormone (TSH)
• Infection serologys: Anti-streptolysin “O” –streptococcus infection (ASO, ASLO)
• Autoimmune test: antinuclear antibody screen (ANA screen), extractable antinuclear antigen (ENA) screen
• Function of the hematopoietic system: iron (Fe), ferritin, transferrin (Trf)
• Blood count with 22 parameters: Blood count: white blood cell (WBC), red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean cell volume (MCV), mean cell (MCH), mean cell hemoglobin concentration (MCHC). Differential count parameters (expressed in % and absolute value): neutrophils (NEUT), lymphocytes (LYMPH), monocytes (MONO), eosinophils (EOS), basophils (BASO), large unstained cells (LUC). Thrombocyte parameters: thrombocyte/platelet (PLT), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT)

Our Tumor marker tests can help identify different types of tumors that most commonly affect men’s health. The package includes laboratory measurements of tumor markers that are elevated in liver, stomach, lung, large intestine (colon), prostate, and testicular lesions.
Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!

A negative result does not exclude the presence of a tumor!

These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer. Among the test parameters, cancer antigen 19-9 (CA-19-9) may indicate pancreatic, bile duct, colon, lung, or gallbladder tumor. Elevated cancer antigen 50 (CA-50) may be the sign of gastrointestinal tumors. CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

β-2-microglobulin (B2M) is produced by the body’s immune system (B lymphocytes) or by tumor cells. It can also be used to diagnose certain kidney diseases (glomerular dysfunction). Its level is elevated in tumors affecting the hematopoietic system (multiple myeloma, lymphoma, B-cell chronic lymphocytic leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma) as well as the testes.

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in gastrointestinal tumors or in breast, lung, liver, pancreatic and ovarian cancers. In non-small cell lung cancer (mainly squamous cell and large cell carcinoma subtypes), CYFRA 21 1 is considered the most suitable biomarker.

In women, Human Chorionic Gonadotropin (hCG) is produced in placental cells and plays a role in the maintenance of the corpus luteum during pregnancy. Its elevated level may indicate pancreatic or testicular tumors.

Lactoferrin is an iron-binding protein that is also present in neutrophil granulocytes involved in the inflammatory immune response. Thus, its level correlates with inflammatory processes in gastrointestinal diseases. Its level may also be elevated in colorectal tumors.

Calprotectin is a calcium-, zinc- and manganese-binding protein produced by neutrophil granulocytes and monocytes. Its level may also be elevated in colorectal tumors.

Prostate-specific antigen (PSA) is produced by the epithelial cells of the prostate gland. PSA levels higher than 10 ng/ml are likely to indicate the presence of prostate cancer. For screening, the free PSA fraction and the total PSA/free PSA ratio are evaluated. Free PSA levels are lower in prostate cancer and higher in prostate enlargement. Annual PSA screening is recommended for people over 45 years of age, as early diagnosis of malignant prostate cancer is curable.

The measurement of neuron-specific enolase (NSE) can be used to monitor the efficacy of therapy and to assess changes in the condition of patients with tumors, particularly small-cell lung cancer and neuroblastoma.

The measurement of S-100 protein can be used to support the management of patients with malignant melanoma and to support the management of patients with brain injury (traumatic brain injury or stroke).

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

The SCC antigen is used for the follow-up of squamous cell carcinomas.
Pro-gastrin-releasing peptide (ProGRP) is a sensitive tumor marker of neuroendocrine cancers.

These tumor markers are not specific!

CA 19-9 levels may also be elevated in biliary cancer, pancreatitis, cystic fibrosis and liver disease.

Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, and liver cirrhosis).

CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

Elevated CYFRA 21 1 levels have also been described in non-malignant diseases (e.g. pneumonia, sepsis) and abnormal kidney function.

High AFP levels may also be seen in hepatitis, cirrhosis and hepatitis.

β-2-microglobulin (B2M) level can be elevated in renal inflammation, autoimmune diseases (systemic lupus erythematosus (SLE)), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS), Crohn’s disease and infections (cytomegalovirus (CMV), nonA-nonB hepatitis, infectious mononucleosis, HIV).

PSA levels can also rise in benign prostatic enlargement (hyperplasia).

Elevated NSE levels may also occur in malignant neuroendocrine diseases, many other tumor diseases and clinical pathologies.

Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

• Tumor markers (serum test): alpha-fetoprotein (AFP), β-2-Microglobulin (B2M), cancer antigen 19-9 (CA-19-9), cancer antigen 50 (CA-50), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA), chromagranin A (CgA), Cyfra-21-1, free β Human Chorionic Gonadotropin (free β-HCG), prostate-specific antigen (PSA), free prostate-specific antigen (PSA free), neuron-specific enolase (NSE), S-100 protein, pro-gastrin-releasing peptide (ProGRP), squamous cell carcinoma (SCC) antigen
• Stool analysis: stool blood, lactoferrin, calprotectin

Our Tumor marker tests can help identify different types of tumors that most commonly affect men. The package includes laboratory measurements for tumor markers that are elevated in liver, prostate, and testicular lesions as well as in neuroendocrine tumors.
Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!

A negative result does not exclude the presence of a tumor!

These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver, ovarian and testicular cancer.

β-2-microglobulin (B2M) is produced by the body’s immune system (B lymphocytes) or by tumor cells. It can also be used to diagnose certain kidney diseases (glomerular dysfunction). Its level is elevated in tumors affecting the hematopoietic system (multiple myeloma, lymphoma, B-cell chronic lymphocytic leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma) as well as the testes.

Elevated level of Human Chorionic Gonadotropin (hCG, free B-HCG ) may indicate pancreatic or testicular tumors in men.

Prostate-specific antigen (PSA) is produced by the epithelial cells of the prostate gland. PSA levels higher than 10 ng/ml are likely to indicate the presence of prostate cancer. For screening, the free PSA fraction and the total PSA/free PSA ratio are evaluated. Free PSA levels are lower in prostate cancer and higher in prostate enlargement. Annual PSA screening is recommended for people over 45 years of age, as early diagnosis of malignant prostate cancer is curable.

Chromogranin A (CgA) can be used to diagnose neuroendocrine tumors and to monitor therapy in treated patients. Neuroendocrine tumors can arise in almost any organ of the human body, most commonly arising from the mucosa of the gastrointestinal tract and pancreas, and the bronchial system. The concentration of chromogranin A correlates with disease activity and tumor size.

These tumor markers are not specific!

High AFP levels may also be seen in hepatitis, cirrhosis and hepatitis.

β-2-microglobulin (B2M) level can be elevated in renal inflammation, autoimmune diseases (systemic lupus erythematosus (SLE)), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS), Crohn’s disease and infections (cytomegalovirus (CMV), nonA-nonB hepatitis, mononucleosis infectiosa, HIV).

PSA levels can also increase in benign prostatic enlargement (hyperplasia).

Chromogranin A may also be elevated in pheochromocytoma, pancreatic and prostate tumors.

• Tumor markers (serum test): alpha-fetoprotein (AFP), β-2-Microglobulin (B2M), free β Human Chorionic Gonadotropin (free β-HCG), chromagranin A (CgA), prostate-specific antigen (PSA), free prostate-specific antigen (PSA free)

Our package, called Tumor markers of the digestive system, includes laboratory measurements for tumor markers that are elevated in liver, ovarian, large intestine (colon), and pancreatic lesions.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!

A negative result does not exclude the presence of a tumor!

These tumor markers are not specific!

When liver cells are formed, alpha-fetoprotein (AFP) is produced. Its level is elevated in liver and ovarian cancer.

Cancer antigen 19-9 (CA-19-9) may indicate the development of tumors of the pancreas, bile duct, colon, lung, gallbladder.

CA 72-4 is parameter to monitor the disease progression and the treatment of patients with gastric and ovarian cancer.

The carcinoembryonic antigen (CEA) is produced by embryonic and tumor cells. Its level can be elevated in gastrointestinal tumors as well as in case of breast, lung, liver, pancreatic and ovarian cancers.

Cancer antigen 242 (CA-242) is the tumor marker of colon- and pancreas cancers.
Elevated cancer antigen 50 (CA-50) may be the sign of gastrointestinal tumors.

Lactoferrin is an iron-binding protein that is also present in neutrophil granulocytes involved in the inflammatory immune response. Thus, its levels are measured in relation to the inflammatory processes in gastrointestinal diseases. Lactoferrin levels can also be elevated in colorectal tumors.

Calprotectin is a calcium-, zinc- and manganese-binding protein produced by neutrophil granulocytes and monocytes. Its level can also be elevated in colorectal tumors.

These tumor markers are not specific!
High AFP values can also be obtained in cases of hepatitis, cirrhosis and hepatitis.

CA 19-9 levels may also be elevated in biliary cancer, pancreatitis, cystic fibrosis and liver disease.

Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, cirrhosis and ovarian cysts).

CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

• Tumor markers (serum test): alpha-fetoprotein (AFP), cancer antigen 19-9 (CA-19-9), cancer antigen 242 (CA-242), cancer antigen 50 (CA-50), cancer antigen 72-4 (CA-72-4), carcinoembryonic antigen (CEA)
• Stool analysis: stool blood, lactoferrin, calprotectin

Our package, called Tumor markers of the respiratory, includes laboratory measurements for tumor markers that are elevated in lung lesions.

Tumor markers can indicate disease recurrence or metastasis several months earlier than imaging techniques or onset of clinical symptoms.

Tumor markers alone are not suitable for exclusive screening!

A negative result does not exclude the presence of a tumor!

These tumor markers are not specific! 

For non-small cell lung cancer, CA 72-4 and CYFRA 21-1 are considered the most suitable biomarkers.

Carcinoembryonic antigen (CEA) is produced by embryonic as well as tumor cells. Its level can also be elevated in lung tumors.

The measurement of neuron-specific enolase (NSE) can be used to monitor the efficacy of therapy and to assess changes in the condition of patients with tumors, particularly small cell lung cancer and neuroblastoma.

These tumor markers are not specific!
Elevated serum levels of CA 72-4 may also occur in certain non-malignant diseases (e.g. pneumonia, pancreatitis, liver cirrhosis and ovarian cysts).

CEA levels may be elevated in inflammation, cirrhosis, ulcers and in heavy smokers.

Elevated CYFRA 21 1 levels have also been described in non-malignant diseases (e.g. pneumonia, sepsis) and abnormal kidney function.

Elevated NSE levels may occur in malignant neuroendocrine diseases, a number of other tumors and clinical pathologies.

• Tumormarkerek (szérumvizsgálat): cancer antigén 72-4 (CA-72-4), carcino-embrionális antigén (CEA), Cyfra-21-1, neuronspecifikus enoláz (NSE)